nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—TYMP—endothelium—malignant glioma	0.0244	0.263	CbGeAlD
Cidofovir—TYMP—blood vessel—malignant glioma	0.0225	0.242	CbGeAlD
Cidofovir—Nephrotoxicity—Carmustine—malignant glioma	0.0209	0.023	CcSEcCtD
Cidofovir—Facial paralysis—Carmustine—malignant glioma	0.0209	0.023	CcSEcCtD
Cidofovir—Hemiplegia—Carmustine—malignant glioma	0.0186	0.0205	CcSEcCtD
Cidofovir—Hemiplegia—Temozolomide—malignant glioma	0.018	0.0198	CcSEcCtD
Cidofovir—Hyperacusis—Temozolomide—malignant glioma	0.0172	0.019	CcSEcCtD
Cidofovir—VIIth nerve paralysis—Carmustine—malignant glioma	0.0162	0.0179	CcSEcCtD
Cidofovir—Personality disorder—Carmustine—malignant glioma	0.0154	0.0169	CcSEcCtD
Cidofovir—Tongue discolouration—Temozolomide—malignant glioma	0.0133	0.0146	CcSEcCtD
Cidofovir—Faecal incontinence—Carmustine—malignant glioma	0.0132	0.0145	CcSEcCtD
Cidofovir—Faecal incontinence—Temozolomide—malignant glioma	0.0127	0.014	CcSEcCtD
Cidofovir—Nephropathy toxic—Carmustine—malignant glioma	0.0116	0.0128	CcSEcCtD
Cidofovir—Myasthenia—Carmustine—malignant glioma	0.0106	0.0117	CcSEcCtD
Cidofovir—Oral candidiasis—Carmustine—malignant glioma	0.0105	0.0115	CcSEcCtD
Cidofovir—Encephalopathy—Carmustine—malignant glioma	0.0104	0.0114	CcSEcCtD
Cidofovir—Oral candidiasis—Temozolomide—malignant glioma	0.0101	0.0111	CcSEcCtD
Cidofovir—Lung disorder—Temozolomide—malignant glioma	0.00907	0.01	CcSEcCtD
Cidofovir—Scotoma—Carmustine—malignant glioma	0.00875	0.00965	CcSEcCtD
Cidofovir—TYMP—medulla oblongata—malignant glioma	0.00857	0.0923	CbGeAlD
Cidofovir—Scotoma—Temozolomide—malignant glioma	0.00846	0.00932	CcSEcCtD
Cidofovir—Otitis media—Temozolomide—malignant glioma	0.00825	0.00909	CcSEcCtD
Cidofovir—Hyperaesthesia—Temozolomide—malignant glioma	0.00818	0.00902	CcSEcCtD
Cidofovir—TYMP—midbrain—malignant glioma	0.00783	0.0844	CbGeAlD
Cidofovir—Speech disorder—Carmustine—malignant glioma	0.00773	0.00852	CcSEcCtD
Cidofovir—TYMP—spinal cord—malignant glioma	0.00764	0.0823	CbGeAlD
Cidofovir—Liver injury—Temozolomide—malignant glioma	0.00763	0.00841	CcSEcCtD
Cidofovir—Accidental injury—Carmustine—malignant glioma	0.00751	0.00828	CcSEcCtD
Cidofovir—Speech disorder—Temozolomide—malignant glioma	0.00747	0.00823	CcSEcCtD
Cidofovir—Leukocytosis—Carmustine—malignant glioma	0.00707	0.0078	CcSEcCtD
Cidofovir—Herpes simplex—Temozolomide—malignant glioma	0.00697	0.00768	CcSEcCtD
Cidofovir—Gait disturbance—Carmustine—malignant glioma	0.00681	0.00751	CcSEcCtD
Cidofovir—Coordination abnormal—Carmustine—malignant glioma	0.00677	0.00746	CcSEcCtD
Cidofovir—Hearing impaired—Temozolomide—malignant glioma	0.00675	0.00744	CcSEcCtD
Cidofovir—Neck pain—Carmustine—malignant glioma	0.00673	0.00742	CcSEcCtD
Cidofovir—Injection site reaction—Carmustine—malignant glioma	0.00661	0.00728	CcSEcCtD
Cidofovir—Gait disturbance—Temozolomide—malignant glioma	0.00658	0.00725	CcSEcCtD
Cidofovir—Coordination abnormal—Temozolomide—malignant glioma	0.00654	0.00721	CcSEcCtD
Cidofovir—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00642	0.00708	CcSEcCtD
Cidofovir—Urinary incontinence—Carmustine—malignant glioma	0.00642	0.00707	CcSEcCtD
Cidofovir—Candida infection—Carmustine—malignant glioma	0.00635	0.00699	CcSEcCtD
Cidofovir—Neuropathy—Carmustine—malignant glioma	0.00624	0.00688	CcSEcCtD
Cidofovir—Urinary incontinence—Temozolomide—malignant glioma	0.0062	0.00684	CcSEcCtD
Cidofovir—TYMP—central nervous system—malignant glioma	0.0062	0.0668	CbGeAlD
Cidofovir—Candida infection—Temozolomide—malignant glioma	0.00613	0.00676	CcSEcCtD
Cidofovir—TYMP—cerebellum—malignant glioma	0.00606	0.0653	CbGeAlD
Cidofovir—Aplastic anaemia—Temozolomide—malignant glioma	0.00603	0.00665	CcSEcCtD
Cidofovir—Neuropathy—Temozolomide—malignant glioma	0.00603	0.00665	CcSEcCtD
Cidofovir—Dry eye—Temozolomide—malignant glioma	0.00593	0.00654	CcSEcCtD
Cidofovir—Abnormal vision—Carmustine—malignant glioma	0.0058	0.00639	CcSEcCtD
Cidofovir—Sepsis—Carmustine—malignant glioma	0.00577	0.00636	CcSEcCtD
Cidofovir—Abnormal vision—Temozolomide—malignant glioma	0.0056	0.00617	CcSEcCtD
Cidofovir—Phlebitis—Carmustine—malignant glioma	0.0056	0.00617	CcSEcCtD
Cidofovir—Ear pain—Temozolomide—malignant glioma	0.00546	0.00602	CcSEcCtD
Cidofovir—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00536	0.00591	CcSEcCtD
Cidofovir—Eye pain—Carmustine—malignant glioma	0.00534	0.00589	CcSEcCtD
Cidofovir—Injury—Carmustine—malignant glioma	0.00525	0.00579	CcSEcCtD
Cidofovir—Deafness—Temozolomide—malignant glioma	0.00521	0.00575	CcSEcCtD
Cidofovir—Eye pain—Temozolomide—malignant glioma	0.00516	0.00569	CcSEcCtD
Cidofovir—Amnesia—Carmustine—malignant glioma	0.00514	0.00566	CcSEcCtD
Cidofovir—Amnesia—Temozolomide—malignant glioma	0.00496	0.00547	CcSEcCtD
Cidofovir—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00494	0.00545	CcSEcCtD
Cidofovir—TYMP—brain—malignant glioma	0.00492	0.053	CbGeAlD
Cidofovir—Thirst—Temozolomide—malignant glioma	0.0049	0.0054	CcSEcCtD
Cidofovir—Hyponatraemia—Carmustine—malignant glioma	0.00484	0.00534	CcSEcCtD
Cidofovir—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00482	0.00532	CcSEcCtD
Cidofovir—Diplopia—Carmustine—malignant glioma	0.00482	0.00532	CcSEcCtD
Cidofovir—SLC22A6—brain—malignant glioma	0.00474	0.051	CbGeAlD
Cidofovir—Diplopia—Temozolomide—malignant glioma	0.00466	0.00514	CcSEcCtD
Cidofovir—Face oedema—Carmustine—malignant glioma	0.00466	0.00513	CcSEcCtD
Cidofovir—Ataxia—Carmustine—malignant glioma	0.00454	0.005	CcSEcCtD
Cidofovir—Face oedema—Temozolomide—malignant glioma	0.0045	0.00496	CcSEcCtD
Cidofovir—Hypokalaemia—Carmustine—malignant glioma	0.00439	0.00484	CcSEcCtD
Cidofovir—Ataxia—Temozolomide—malignant glioma	0.00438	0.00483	CcSEcCtD
Cidofovir—Dehydration—Temozolomide—malignant glioma	0.00434	0.00478	CcSEcCtD
Cidofovir—Dry skin—Temozolomide—malignant glioma	0.00427	0.00471	CcSEcCtD
Cidofovir—Muscular weakness—Carmustine—malignant glioma	0.00426	0.00469	CcSEcCtD
Cidofovir—Hypokalaemia—Temozolomide—malignant glioma	0.00424	0.00468	CcSEcCtD
Cidofovir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0042	0.00463	CcSEcCtD
Cidofovir—Dysphagia—Carmustine—malignant glioma	0.00417	0.0046	CcSEcCtD
Cidofovir—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00411	0.00453	CcSEcCtD
Cidofovir—Muscular weakness—Temozolomide—malignant glioma	0.00411	0.00453	CcSEcCtD
Cidofovir—Dysphagia—Temozolomide—malignant glioma	0.00403	0.00444	CcSEcCtD
Cidofovir—Pancytopenia—Carmustine—malignant glioma	0.00396	0.00437	CcSEcCtD
Cidofovir—Neutropenia—Carmustine—malignant glioma	0.0039	0.0043	CcSEcCtD
Cidofovir—Bronchitis—Temozolomide—malignant glioma	0.00388	0.00427	CcSEcCtD
Cidofovir—Pancytopenia—Temozolomide—malignant glioma	0.00383	0.00422	CcSEcCtD
Cidofovir—Dysuria—Temozolomide—malignant glioma	0.00377	0.00415	CcSEcCtD
Cidofovir—Neutropenia—Temozolomide—malignant glioma	0.00377	0.00415	CcSEcCtD
Cidofovir—Hyperglycaemia—Carmustine—malignant glioma	0.00376	0.00415	CcSEcCtD
Cidofovir—Pneumonia—Carmustine—malignant glioma	0.00374	0.00412	CcSEcCtD
Cidofovir—Pollakiuria—Temozolomide—malignant glioma	0.00372	0.0041	CcSEcCtD
Cidofovir—Photosensitivity reaction—Temozolomide—malignant glioma	0.00368	0.00405	CcSEcCtD
Cidofovir—Weight increased—Temozolomide—malignant glioma	0.00367	0.00404	CcSEcCtD
Cidofovir—Renal failure—Carmustine—malignant glioma	0.00365	0.00403	CcSEcCtD
Cidofovir—Weight decreased—Temozolomide—malignant glioma	0.00365	0.00402	CcSEcCtD
Cidofovir—Neuropathy peripheral—Carmustine—malignant glioma	0.00364	0.00402	CcSEcCtD
Cidofovir—Hyperglycaemia—Temozolomide—malignant glioma	0.00364	0.00401	CcSEcCtD
Cidofovir—Stomatitis—Carmustine—malignant glioma	0.00362	0.00399	CcSEcCtD
Cidofovir—Urinary tract infection—Carmustine—malignant glioma	0.00361	0.00398	CcSEcCtD
Cidofovir—Pneumonia—Temozolomide—malignant glioma	0.00361	0.00398	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00356	0.00393	CcSEcCtD
Cidofovir—Neuropathy peripheral—Temozolomide—malignant glioma	0.00352	0.00388	CcSEcCtD
Cidofovir—Stomatitis—Temozolomide—malignant glioma	0.0035	0.00386	CcSEcCtD
Cidofovir—Urinary tract infection—Temozolomide—malignant glioma	0.00349	0.00385	CcSEcCtD
Cidofovir—Sinusitis—Temozolomide—malignant glioma	0.00337	0.00372	CcSEcCtD
Cidofovir—Hallucination—Carmustine—malignant glioma	0.00332	0.00366	CcSEcCtD
Cidofovir—Oedema peripheral—Carmustine—malignant glioma	0.00329	0.00362	CcSEcCtD
Cidofovir—Hepatitis—Temozolomide—malignant glioma	0.00323	0.00356	CcSEcCtD
Cidofovir—Visual impairment—Carmustine—malignant glioma	0.00322	0.00355	CcSEcCtD
Cidofovir—Hallucination—Temozolomide—malignant glioma	0.00321	0.00354	CcSEcCtD
Cidofovir—Pharyngitis—Temozolomide—malignant glioma	0.0032	0.00353	CcSEcCtD
Cidofovir—Urinary tract disorder—Temozolomide—malignant glioma	0.00319	0.00351	CcSEcCtD
Cidofovir—Oedema peripheral—Temozolomide—malignant glioma	0.00318	0.0035	CcSEcCtD
Cidofovir—Urethral disorder—Temozolomide—malignant glioma	0.00316	0.00349	CcSEcCtD
Cidofovir—Eye disorder—Carmustine—malignant glioma	0.00312	0.00344	CcSEcCtD
Cidofovir—Visual impairment—Temozolomide—malignant glioma	0.00311	0.00343	CcSEcCtD
Cidofovir—Flushing—Carmustine—malignant glioma	0.0031	0.00341	CcSEcCtD
Cidofovir—Erythema multiforme—Temozolomide—malignant glioma	0.00305	0.00336	CcSEcCtD
Cidofovir—Eye disorder—Temozolomide—malignant glioma	0.00301	0.00332	CcSEcCtD
Cidofovir—Tinnitus—Temozolomide—malignant glioma	0.00301	0.00331	CcSEcCtD
Cidofovir—Flushing—Temozolomide—malignant glioma	0.00299	0.0033	CcSEcCtD
Cidofovir—Alopecia—Carmustine—malignant glioma	0.00295	0.00325	CcSEcCtD
Cidofovir—Angiopathy—Temozolomide—malignant glioma	0.00293	0.00323	CcSEcCtD
Cidofovir—Mediastinal disorder—Temozolomide—malignant glioma	0.00291	0.0032	CcSEcCtD
Cidofovir—Chills—Temozolomide—malignant glioma	0.00289	0.00319	CcSEcCtD
Cidofovir—Alopecia—Temozolomide—malignant glioma	0.00285	0.00314	CcSEcCtD
Cidofovir—Back pain—Carmustine—malignant glioma	0.00281	0.0031	CcSEcCtD
Cidofovir—Dysgeusia—Temozolomide—malignant glioma	0.00275	0.00303	CcSEcCtD
Cidofovir—Tremor—Carmustine—malignant glioma	0.00272	0.003	CcSEcCtD
Cidofovir—Back pain—Temozolomide—malignant glioma	0.00272	0.00299	CcSEcCtD
Cidofovir—Anaemia—Carmustine—malignant glioma	0.00269	0.00296	CcSEcCtD
Cidofovir—Agitation—Carmustine—malignant glioma	0.00267	0.00294	CcSEcCtD
Cidofovir—Tremor—Temozolomide—malignant glioma	0.00263	0.0029	CcSEcCtD
Cidofovir—Ill-defined disorder—Temozolomide—malignant glioma	0.00261	0.00287	CcSEcCtD
Cidofovir—Leukopenia—Carmustine—malignant glioma	0.0026	0.00287	CcSEcCtD
Cidofovir—Anaemia—Temozolomide—malignant glioma	0.0026	0.00286	CcSEcCtD
Cidofovir—Agitation—Temozolomide—malignant glioma	0.00258	0.00284	CcSEcCtD
Cidofovir—Angioedema—Temozolomide—malignant glioma	0.00257	0.00283	CcSEcCtD
Cidofovir—Malaise—Temozolomide—malignant glioma	0.00253	0.00279	CcSEcCtD
Cidofovir—Vertigo—Temozolomide—malignant glioma	0.00252	0.00278	CcSEcCtD
Cidofovir—Convulsion—Carmustine—malignant glioma	0.00252	0.00277	CcSEcCtD
Cidofovir—Leukopenia—Temozolomide—malignant glioma	0.00251	0.00277	CcSEcCtD
Cidofovir—Hypertension—Carmustine—malignant glioma	0.00251	0.00277	CcSEcCtD
Cidofovir—Chest pain—Carmustine—malignant glioma	0.00247	0.00273	CcSEcCtD
Cidofovir—Myalgia—Carmustine—malignant glioma	0.00247	0.00273	CcSEcCtD
Cidofovir—Anxiety—Carmustine—malignant glioma	0.00247	0.00272	CcSEcCtD
Cidofovir—Cough—Temozolomide—malignant glioma	0.00245	0.0027	CcSEcCtD
Cidofovir—Convulsion—Temozolomide—malignant glioma	0.00243	0.00268	CcSEcCtD
Cidofovir—Hypertension—Temozolomide—malignant glioma	0.00242	0.00267	CcSEcCtD
Cidofovir—Confusional state—Carmustine—malignant glioma	0.00239	0.00264	CcSEcCtD
Cidofovir—Myalgia—Temozolomide—malignant glioma	0.00239	0.00263	CcSEcCtD
Cidofovir—Arthralgia—Temozolomide—malignant glioma	0.00239	0.00263	CcSEcCtD
Cidofovir—Anxiety—Temozolomide—malignant glioma	0.00238	0.00263	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00237	0.00262	CcSEcCtD
Cidofovir—Oedema—Carmustine—malignant glioma	0.00237	0.00261	CcSEcCtD
Cidofovir—Discomfort—Temozolomide—malignant glioma	0.00236	0.0026	CcSEcCtD
Cidofovir—Infection—Carmustine—malignant glioma	0.00236	0.0026	CcSEcCtD
Cidofovir—Dry mouth—Temozolomide—malignant glioma	0.00234	0.00258	CcSEcCtD
Cidofovir—Thrombocytopenia—Carmustine—malignant glioma	0.00232	0.00256	CcSEcCtD
Cidofovir—Tachycardia—Carmustine—malignant glioma	0.00231	0.00255	CcSEcCtD
Cidofovir—Confusional state—Temozolomide—malignant glioma	0.00231	0.00255	CcSEcCtD
Cidofovir—Anaphylactic shock—Temozolomide—malignant glioma	0.00229	0.00253	CcSEcCtD
Cidofovir—Oedema—Temozolomide—malignant glioma	0.00229	0.00253	CcSEcCtD
Cidofovir—Infection—Temozolomide—malignant glioma	0.00228	0.00251	CcSEcCtD
Cidofovir—Anorexia—Carmustine—malignant glioma	0.00226	0.00249	CcSEcCtD
Cidofovir—Nervous system disorder—Temozolomide—malignant glioma	0.00225	0.00248	CcSEcCtD
Cidofovir—Thrombocytopenia—Temozolomide—malignant glioma	0.00224	0.00247	CcSEcCtD
Cidofovir—Skin disorder—Temozolomide—malignant glioma	0.00223	0.00245	CcSEcCtD
Cidofovir—Hypotension—Carmustine—malignant glioma	0.00222	0.00244	CcSEcCtD
Cidofovir—Hyperhidrosis—Temozolomide—malignant glioma	0.00222	0.00244	CcSEcCtD
Cidofovir—Anorexia—Temozolomide—malignant glioma	0.00218	0.00241	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00216	0.00238	CcSEcCtD
Cidofovir—Insomnia—Carmustine—malignant glioma	0.00214	0.00236	CcSEcCtD
Cidofovir—Paraesthesia—Carmustine—malignant glioma	0.00213	0.00235	CcSEcCtD
Cidofovir—Dyspnoea—Carmustine—malignant glioma	0.00211	0.00233	CcSEcCtD
Cidofovir—Somnolence—Carmustine—malignant glioma	0.00211	0.00232	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00209	0.0023	CcSEcCtD
Cidofovir—Insomnia—Temozolomide—malignant glioma	0.00207	0.00228	CcSEcCtD
Cidofovir—Decreased appetite—Carmustine—malignant glioma	0.00206	0.00227	CcSEcCtD
Cidofovir—Paraesthesia—Temozolomide—malignant glioma	0.00206	0.00227	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00205	0.00226	CcSEcCtD
Cidofovir—Dyspnoea—Temozolomide—malignant glioma	0.00204	0.00225	CcSEcCtD
Cidofovir—Somnolence—Temozolomide—malignant glioma	0.00204	0.00225	CcSEcCtD
Cidofovir—Pain—Carmustine—malignant glioma	0.00203	0.00224	CcSEcCtD
Cidofovir—Constipation—Carmustine—malignant glioma	0.00203	0.00224	CcSEcCtD
Cidofovir—Dyspepsia—Temozolomide—malignant glioma	0.00202	0.00222	CcSEcCtD
Cidofovir—Decreased appetite—Temozolomide—malignant glioma	0.00199	0.0022	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00198	0.00218	CcSEcCtD
Cidofovir—Pain—Temozolomide—malignant glioma	0.00196	0.00216	CcSEcCtD
Cidofovir—Constipation—Temozolomide—malignant glioma	0.00196	0.00216	CcSEcCtD
Cidofovir—Feeling abnormal—Carmustine—malignant glioma	0.00195	0.00215	CcSEcCtD
Cidofovir—Gastrointestinal pain—Carmustine—malignant glioma	0.00194	0.00214	CcSEcCtD
Cidofovir—Feeling abnormal—Temozolomide—malignant glioma	0.00189	0.00208	CcSEcCtD
Cidofovir—Abdominal pain—Carmustine—malignant glioma	0.00187	0.00207	CcSEcCtD
Cidofovir—Body temperature increased—Carmustine—malignant glioma	0.00187	0.00207	CcSEcCtD
Cidofovir—Gastrointestinal pain—Temozolomide—malignant glioma	0.00187	0.00207	CcSEcCtD
Cidofovir—Urticaria—Temozolomide—malignant glioma	0.00182	0.00201	CcSEcCtD
Cidofovir—Body temperature increased—Temozolomide—malignant glioma	0.00181	0.002	CcSEcCtD
Cidofovir—Abdominal pain—Temozolomide—malignant glioma	0.00181	0.002	CcSEcCtD
Cidofovir—Hypersensitivity—Carmustine—malignant glioma	0.00175	0.00193	CcSEcCtD
Cidofovir—Asthenia—Carmustine—malignant glioma	0.0017	0.00188	CcSEcCtD
Cidofovir—Hypersensitivity—Temozolomide—malignant glioma	0.00169	0.00186	CcSEcCtD
Cidofovir—Asthenia—Temozolomide—malignant glioma	0.00164	0.00181	CcSEcCtD
Cidofovir—Diarrhoea—Carmustine—malignant glioma	0.00162	0.00179	CcSEcCtD
Cidofovir—Pruritus—Temozolomide—malignant glioma	0.00162	0.00179	CcSEcCtD
Cidofovir—Dizziness—Carmustine—malignant glioma	0.00157	0.00173	CcSEcCtD
Cidofovir—Diarrhoea—Temozolomide—malignant glioma	0.00157	0.00173	CcSEcCtD
Cidofovir—Dizziness—Temozolomide—malignant glioma	0.00152	0.00167	CcSEcCtD
Cidofovir—Vomiting—Carmustine—malignant glioma	0.00151	0.00166	CcSEcCtD
Cidofovir—Rash—Carmustine—malignant glioma	0.0015	0.00165	CcSEcCtD
Cidofovir—Dermatitis—Carmustine—malignant glioma	0.00149	0.00165	CcSEcCtD
Cidofovir—Headache—Carmustine—malignant glioma	0.00149	0.00164	CcSEcCtD
Cidofovir—Vomiting—Temozolomide—malignant glioma	0.00146	0.00161	CcSEcCtD
Cidofovir—Rash—Temozolomide—malignant glioma	0.00144	0.00159	CcSEcCtD
Cidofovir—Dermatitis—Temozolomide—malignant glioma	0.00144	0.00159	CcSEcCtD
Cidofovir—Headache—Temozolomide—malignant glioma	0.00144	0.00158	CcSEcCtD
Cidofovir—Nausea—Carmustine—malignant glioma	0.00141	0.00155	CcSEcCtD
Cidofovir—Nausea—Temozolomide—malignant glioma	0.00136	0.0015	CcSEcCtD
